Source:http://linkedlifedata.com/resource/pubmed/id/17129741
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0028754,
umls-concept:C0043157,
umls-concept:C0166415,
umls-concept:C0205245,
umls-concept:C0220938,
umls-concept:C0242339,
umls-concept:C0392762,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C1882417,
umls-concept:C2603343
|
pubmed:issue |
2
|
pubmed:dateCreated |
2007-1-22
|
pubmed:abstractText |
Peroxisome proliferator-activated receptor-alpha (PPARalpha) is a nuclear receptor capable of regulating the expression of genes involved in peroxisomal and mitochondrial beta-oxidation pathways. The common Leu162Val polymorphism in the gene encoding PPARalpha has inconsistently shown association with quantitative traits related to obesity, type 2 diabetes, and dyslipidaemia. We genotyped the Leu162Val polymorphism in 1383 patients with type 2 diabetes and 4401 control subjects with normal glucose tolerance (NGT) without showing any association between diabetes and genotype. In addition, the Leu162Val polymorphism was not associated with WHO-defined obesity or dyslipidaemia in case-control settings involving 961 obese and 2563 lean subjects and 1399 dyslipidaemic and 4399 normolipidaemic subjects, respectively. Quantitative trait studies of metabolic variables were carried out in 5799 middle-aged, treatment-naïve subjects showing a difference in fasting serum triglyceride concentrations among homozygous Val-carriers (Leu/Leu+Leu/Val, n=5782, 1.33+/-1.35 mmol/l vs. Val/Val, n=17, 2.22+/-2.4 mmol/l, p=0.007). Similarly, Val/Val was associated with increased fasting serum total cholesterol concentrations (p=0.01). In conclusion, in a relative large-scale study of middle-aged whites we found no evidence of association between the PPARalpha Leu162Val polymorphism and obesity or type 2 diabetes. If replicated, the Val162Val variant may, however, confer an increase in fasting levels of serum lipids.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1096-7192
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
205-9
|
pubmed:meshHeading |
pubmed-meshheading:17129741-Aged,
pubmed-meshheading:17129741-Case-Control Studies,
pubmed-meshheading:17129741-Denmark,
pubmed-meshheading:17129741-Diabetes Mellitus, Type 2,
pubmed-meshheading:17129741-Dyslipidemias,
pubmed-meshheading:17129741-European Continental Ancestry Group,
pubmed-meshheading:17129741-Female,
pubmed-meshheading:17129741-Humans,
pubmed-meshheading:17129741-Male,
pubmed-meshheading:17129741-Middle Aged,
pubmed-meshheading:17129741-Obesity,
pubmed-meshheading:17129741-PPAR alpha,
pubmed-meshheading:17129741-Polymorphism, Genetic,
pubmed-meshheading:17129741-Quantitative Trait, Heritable
|
pubmed:year |
2007
|
pubmed:articleTitle |
Relationships between the functional PPARalpha Leu162Val polymorphism and obesity, type 2 diabetes, dyslipidaemia, and related quantitative traits in studies of 5799 middle-aged white people.
|
pubmed:affiliation |
Steno Diabetes Center, 521, Niels Steensens Vej 2, 2820 Gentofte, Denmark. tspr@steno.dk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|